Chartwell Investment Partners, LLC Fibrogen Inc Transaction History

Chartwell Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$34.58 - $48.06 $608,227 - $845,327	-17,589 Closed	0 $0
Q2 2019 Aug 19, 2019	SELL	$35.13 - $55.53 $930,382 - $1.47 Million	-26,484 Reduced 60.09%	17,589 $795,000
Q1 2019 Apr 11, 2019	BUY	$42.83 - $59.91 $25,612 - $35,826	598 Added 1.38%	44,073 $2.4 Million
Q4 2018 Feb 01, 2019	BUY	$37.97 - $60.16 $401,494 - $636,131	10,574 Added 32.14%	43,475 $2.01 Million
Q3 2018 Nov 08, 2018	BUY	$56.3 - $67.25 $1.85 Million - $2.21 Million	32,901 New	32,901 $2 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.